Matthew E Korenberg is President & COO of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 50,777 shares of LGND, which is worth approximately $5.94 Million. The most recent transaction as insider was on Sep 23, 2024, when has been sold 9,772 shares (Common Stock) at a price of $101.24 per share, resulting in proceeds of $989,317. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.8K
41.37% 3M change
48.77% 12M change
Total Value Held $5.94 Million

Matthew E Korenberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 23 2024
SELL
Open market or private sale
$989,317 $101.24 p/Share
9,772 Reduced 16.14%
50,777 Common Stock
Sep 23 2024
BUY
Exercise of conversion of derivative security
$502,476 $51.42 p/Share
9,772 Added 13.9%
60,549 Common Stock
Sep 20 2024
SELL
Open market or private sale
$653,227 $104.1 p/Share
6,275 Reduced 11.0%
50,777 Common Stock
Sep 20 2024
BUY
Exercise of conversion of derivative security
$249,050 $49.99 p/Share
4,982 Added 8.03%
57,052 Common Stock
Sep 16 2024
SELL
Payment of exercise price or tax liability
$337,470 $105.0 p/Share
3,214 Reduced 5.81%
52,070 Common Stock
Sep 16 2024
BUY
Exercise of conversion of derivative security
$325,018 $56.29 p/Share
5,774 Added 9.66%
54,008 Common Stock
Aug 26 2024
SELL
Open market or private sale
$1,203,475 $105.67 p/Share
11,389 Reduced 18.7%
49,510 Common Stock
Aug 23 2024
SELL
Open market or private sale
$660,298 $104.61 p/Share
6,312 Reduced 9.39%
60,899 Common Stock
Aug 22 2024
SELL
Open market or private sale
$122,109 $105.54 p/Share
1,157 Reduced 1.69%
67,211 Common Stock
Aug 09 2024
SELL
Open market or private sale
$1,797,132 $98.5 p/Share
18,245 Reduced 21.06%
68,368 Common Stock
Jun 28 2024
BUY
Other acquisition or disposition
$21,248 $60.71 p/Share
350 Added 0.4%
86,613 Common Stock
May 14 2024
SELL
Open market or private sale
$1,208,810 $85.38 p/Share
14,158 Reduced 14.1%
86,263 Common Stock
May 13 2024
SELL
Open market or private sale
$290,817 $84.54 p/Share
3,440 Reduced 3.31%
100,421 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
14,416 Added 12.19%
103,861 Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$356,677 $74.65 p/Share
4,778 Reduced 5.07%
89,445 Common Stock
Jan 02 2024
SELL
Payment of exercise price or tax liability
$210,928 $72.31 p/Share
2,917 Reduced 3.0%
94,223 Common Stock
Dec 05 2023
SELL
Payment of exercise price or tax liability
$118,266 $59.61 p/Share
1,984 Reduced 2.0%
97,140 Common Stock
Jun 30 2023
BUY
Other acquisition or disposition
$21,349 $56.78 p/Share
376 Added 0.38%
99,124 Common Stock
Feb 23 2023
BUY
Grant, award, or other acquisition
-
9,069 Added 8.41%
98,748 Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$210,912 $72.98 p/Share
2,890 Reduced 3.12%
89,679 Common Stock
Dec 28 2022
SELL
Payment of exercise price or tax liability
$255,813 $66.29 p/Share
3,859 Reduced 4.0%
92,569 Common Stock
Dec 13 2022
BUY
Grant, award, or other acquisition
-
14,000 Added 12.68%
96,428 Common Stock
Nov 30 2022
SELL
Payment of exercise price or tax liability
$261,929 $72.9 p/Share
3,593 Reduced 4.18%
82,428 Common Stock
Nov 01 2022
BUY
Grant, award, or other acquisition
-
27,714 Added 24.37%
86,021 Common Stock
Jun 30 2022
BUY
Other acquisition or disposition
$12,438 $75.84 p/Share
164 Added 0.31%
52,532 Common Stock

Also insider at

QLGN
Qualigen Therapeutics, Inc. Healthcare
LNDC
LANDEC CORP \CA\ Healthcare
MEK

Matthew E Korenberg

President & COO
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND